Biography

Dr Deng is currently an Early Career Fellowship of Cancer Institute NSW. Dr Deng received his Ph.D. degree (specialising in point-of-care biosensing and Biomedical Engineering, 2021) from the University of New South Wales (UNSW), Sydney, Australia. Dr Deng’s research interests include point-of-care biosensing device, CRISPR biosensing device and in vivo biosensing device. To date, Dr Deng has published over 30 journal articles, including Nature Communications, AFM, Small etc. In addition, he has secured over $11M research grants, including AEA, CRCP, NHMRC Idea Grant, ARC Discovery Project etc. His biosensor research has been well recognized by industry, leading to a startup company (Casbio Pty Ltd, co-founder) and a research consultant of Avicena Systems Limited.

My Grants

Early Career Fellowship of Cancer Institute NSW, 2025-2027, sole-CI
NICE-UNSW "Proof-of-Scale" Fund, 2024-2025, CIA
Australia's Economic Accelerator, 2024-2025, CIA
Cooperative Research Centres Projects, 2024-2026, co-CI
UNSW-Tsinghua Collaborative Research Seed Program, 2023, co-CI
NHMRC Idea Grant, 2024-2026, co-CI
ARC Discovery Project, 2024-2026, co-CI
UNSW_NMHA Seed Funidng, 2023, co-CI
Torch Innovation, 2023, CIA
Health Security Systems Australia, 2023, co-CI.
NSSN Grand Challenge Fund, 2023, co-CI.
3Rs Grant from UNSW, 2022, co-CI.
Industry competitive research award, 2022-2024, co-CI.
Two Innovation connections grants, 2021 (RG211246, RG210091), CI on both.
One EDI and ECAN seed funding from UNSW, 2021, CIA.

My Awards

Royal Society of New South Wales Early Career Research and Service Citation Award (2024)
Australian Centre for NanoMedicine (ACN) Travel Award (2023)
Diversity in Engineering Academic Visitors Funding Award (2023)
UNSW Engineering ECA Awards – Innovation and Engagement Award (2022)
Diversity in Engineering Academic Visitors Funding Award (2023)
ARC Centre for Nanoscale BioPhotonics (CNBP) Travel Award (2022)
Australian Centre for NanoMedicine (ACN) Travel Award (2022)
PhD Scholarship in Sandwich assay based deployable biosensors (2017-2021)
Excellent Graduate Thesis (Master, 2016)
Foreigners Scholarship (Master, 2013-2016)
Secondary Prize of Tianjin chemistry competition (Bachelor, 2011)

My Research Activities

Patent

CRISPR/Cas-associated detection assays, methods and kits. (2023) PCT Patent. International application No. PCT/AU2022/050829.
Ultrasensitive CRISPR biosensors assisted by nucleic acid mediators. (2023) PCT Patent. International application No. PCT/AU2023/051144.
Biosensor. (2023) Australian provisional patent No. P0046904AU

My Research Supervision

Supervision keywords

clinical diagnostics

biosensing techniques

Areas of supervision

1. Point-of-care biosensing

2.CRISPR biosensing

3. In vivo biosensing

Currently supervising

PhD Supervision Experience

Co-supervising PhD research project: Development of rapid and sensitive methods for the detection of waterborne pathogens , 2024 (J. Arona)
Co-supervising PhD research project: Programmable nucleases and applications in biosensing, 2023 (X. Zhai)
Joint-supervising PhD research project: Novel biosensors for exosome detection, 2023 (P. Mohammadnejad)
Co-supervising PhD research project: Capture and detection of waterborne parasites using existing and emergent technologies, 2021 (T. Hall)

Thesis students

Primary-supervised PG Thesis project: CRISPR/Cas powered aptasensor for the point-of-care diagnosis of IBD (K. Lyu), 2024
Primary-supervised PG Thesis project: Precision diagnosis of single gene diseases using CRISPR technology (Y. Lin), 2024
Primary-supervised UG Thesis project: Precision diagnosis of inflammatory bowel disease using CRISPR technology (S. Xue), 2023-2024
Primary-supervised UG Thesis project: CRISPR/Cas12a Mediated Biosensing Assay for Point-of-Care Testing of Calprotectin (S. Chia), 2023
Primary-supervised PG Thesis project: Point-of-care testing of procalcitonin using lateral flow assay (J. Deodhar), 2023